National Health Investors (NHI) has disclosed a new risk, in the Corporate Activity and Growth category.
National Health Investors may face significant risks if it chooses to engage in forward sale agreements in the future, particularly under its at-the-market equity distribution program. These agreements could expose the company to uncertainties similar to those it has previously encountered, as outlined in prior risk assessments. This potential exposure underscores the need for careful strategic planning and risk management. Investors and stakeholders should remain vigilant about how such agreements might impact the company’s financial stability and market performance.
The average NHI stock price target is $90.00, implying 17.25% upside potential.
To learn more about National Health Investors’ risk factors, click here.
